https://alert.psychnews.org/2022/06/mortality-lower-with-pimavanserin-than.html
“Pimavanserin, a serotonin 5-HT2 receptor antagonist, is the only drug approved in the United States for treatment of hallucinations and delusions associated with Parkinson’s disease psychosis.”
